700 related articles for article (PubMed ID: 14701854)
1. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
Sah JF; Balasubramanian S; Eckert RL; Rorke EA
J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
[TBL] [Abstract][Full Text] [Related]
2. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
Bhatia N; Agarwal C; Agarwal R
Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294
[TBL] [Abstract][Full Text] [Related]
3. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols (-)-epigallocatechin-3-gallate and theaflavin-3,3'-digallate.
Chung JY; Park JO; Phyu H; Dong Z; Yang CS
FASEB J; 2001 Sep; 15(11):2022-4. PubMed ID: 11511526
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
Gupta S; Hussain T; Mukhtar H
Arch Biochem Biophys; 2003 Feb; 410(1):177-85. PubMed ID: 12559991
[TBL] [Abstract][Full Text] [Related]
7. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
Sah JF; Eckert RL; Chandraratna RA; Rorke EA
J Biol Chem; 2002 Mar; 277(12):9728-35. PubMed ID: 11788593
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate enhances ischemia/reperfusion-induced apoptosis in human umbilical vein endothelial cells via AKT and MAPK pathways.
Zhang T; Yang D; Fan Y; Xie P; Li H
Apoptosis; 2009 Oct; 14(10):1245-54. PubMed ID: 19669889
[TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
10. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells.
Higashi N; Kohjima M; Fukushima M; Ohta S; Kotoh K; Enjoji M; Kobayashi N; Nakamuta M
J Lab Clin Med; 2005 Jun; 145(6):316-22. PubMed ID: 15976760
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB
J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226
[TBL] [Abstract][Full Text] [Related]
13. Antimitogenic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways.
Hung PF; Wu BT; Chen HC; Chen YH; Chen CL; Wu MH; Liu HC; Lee MJ; Kao YH
Am J Physiol Cell Physiol; 2005 May; 288(5):C1094-108. PubMed ID: 15647388
[TBL] [Abstract][Full Text] [Related]
14. Growth factor-dependent induction of p21(CIP1) by the green tea polyphenol, epigallocatechin gallate.
Liberto M; Cobrinik D
Cancer Lett; 2000 Jun; 154(2):151-61. PubMed ID: 10806303
[TBL] [Abstract][Full Text] [Related]
15. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes.
Chung JH; Han JH; Hwang EJ; Seo JY; Cho KH; Kim KH; Youn JI; Eun HC
FASEB J; 2003 Oct; 17(13):1913-5. PubMed ID: 12897059
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47D.
Deguchi H; Fujii T; Nakagawa S; Koga T; Shirouzu K
Int J Oncol; 2002 Dec; 21(6):1301-5. PubMed ID: 12429981
[TBL] [Abstract][Full Text] [Related]
18. Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells.
Bhatia N; Agarwal R
Prostate; 2001 Feb; 46(2):98-107. PubMed ID: 11170137
[TBL] [Abstract][Full Text] [Related]
19. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).
Ahn HY; Hadizadeh KR; Seul C; Yun YP; Vetter H; Sachinidis A
Mol Biol Cell; 1999 Apr; 10(4):1093-104. PubMed ID: 10198059
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
